Subscribe

Corporate and Institutional Access

As the biotech landscape shifts rapidly, our 2026 packages have been designed to provide your team with seamless access to high-impact data and news updates. We offer three distinct tiers to ensure that, whether you are a specialized team or a global institution, you have the insights necessary to drive informed decision-making.

Small Team

Corporate

Institutional
USD 1,900/year USD 5,900/year USD 9,900/year
  • Optimized for up to 20 users
  • full digital access to the ISAAA Brief 57. Global Status of Commercialized GM/Biotech Crops: 2024
  • all weekly updates
  • Designed for up to 50 users
  • 10 print copies of ISAAA Brief 57. Global Status of Commercialized GM/Biotech Crops: 2024
  • all weekly updates
  • Our most comprehensive tier offering unlimited user access
  • 50 print copies of ISAAA Brief 57. Global Status of Commercialized GM/Biotech Crops: 2024
  • full suite of digital supplements
  • all weekly updates
Subscribe Subscribe Subscribe

 

Contact us at knowledgecenter@isaaa.org for more details.